Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it has ...
Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.
Indore: Amid the ongoing water contamination crisis in Bhagirathpura locality, which has claimed multiple lives and affected ...
The lab, which expands upon an effort by UCSD and Scripps Research, will use wastewater analysis to detect flu, COVID and RSV ...
GlobalData on MSN
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx
The addition of Bako and StrataDx is anticipated to bolster Fulgent’s lab services business with the inclusion of new ...
Fulgent Genetics ( ($FLGT) ) has shared an update. On December 20, 2025, Fulgent Genetics’ subsidiary Inform Diagnostics signed agreements to buy ...
GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...
WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...
After COVID-19 NPIs lifted, respiratory infections reverted toward pre pandemic seasonality, with winter peaks for RSV and ...
GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback